Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

ER - AlzChem Group AG: Sales and earnings in the first half-year 2019 in line with full-year forecast

Company: AlzChem Group AG Date: 2019-08-14 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 News Details

Corporate | 14 August 2019 06:30

#   

AlzChem Group AG: Sales and earnings in the first half-year 2019 in line with full-year forecast

DGAP-News: AlzChem Group AG / Key word(s): Half Year Results  

  

14.08.2019 / 06:30  

The issuer is solely responsible for the content of this announcement.  

  

- - -

**AlzChem Group AG: Sales and earnings in the** **first half-year 2019 in line with full-year forecast**

-   **Development at Creamino remains pleasing – start of additional production capacities initiated in August 2019 with first functional tests**
-   **Investment phase at NITRALZ (R) completed within schedule and budget – commissioning – commissioning in progress**

  

**Trostberg, August 14, 2019** – AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, continued to develop in line with its full-year forecast in terms of both sales and earnings in the first half-year 2019. In the first six months, the company generated consolidated sales of EUR 188.2 million (first half-year 2018: EUR 195.2 million). In the Basics & Intermediates segment, the basic chemical products in particular performed well, confirming the strategic expansion of the NITRALZ (R) plant, which was completed within schedule and budget. However, the sales increase in the Basics & Intermediates segment could not fully offset the expected sales decline in the Specialty Chemicals segment. In contrast, expectations for Creamino were fully met. The own distribution and the entry into new regions and countries through newly obtained approvals continue according to plan. The new Creamino plant, which triples production capacity, is already being commissioned with first functional tests.

On the earnings side, AlzChem generated consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 27.9 million in the first half-year 2019, compared with EUR 31.0 million in the same period of the previous year. This was due to high raw material costs, which are expected to fall again in the further course of the year, and the postponement of some orders to the second half-year. The EBITDA margin amounted to 14.8% compared with 15.9% in the same period of the previous year. The consolidated net income for the period amounted to EUR 11.9 million (first half-year 2018: EUR 16.1 million).

For the full year 2019, AlzChem Group AG continues to expect consolidated sales between EUR 389.9 million and EUR 398.9 million (2018: EUR 375.2 million) and adjusted EBITDA between EUR 46.5 million and EUR 51.9 million (2018: EUR 49.4 million). The main drivers should be the continued growth of the Creamino business, the processing of seasonally postponed orders and the expected easing on the raw material markets.

The detailed half-year financial report 2019 is available for download on the website www.alzchem.com under Investor Relations/Publications/Financial Reports.

**About AlzChem**  

The AlzChem Group is a vertically integrated manufacturer of chemical products based on the so-called NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding that are used in a wide variety of different industries. The Group has a leading position in select niche markets. The strategic focus of growth and the main focus of its extensive research and development are on the business segment Specialty Chemicals. The company has around 1,560 employees at four sites in Germany and three other sites abroad.

  

- - -

14.08.2019 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.  

The issuer is solely responsible for the content of this announcement.  

  

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.  

Archive at www.dgap.de  

- - -

|     |     |
| --- | --- |
| Language: | English |
| Company: | AlzChem Group AG |
|     | Dr.-Albert-Frank-Str. 32 |
|     | 83308 Trostberg |
|     | Germany |
| Phone: | +498621862888 |
| Fax: | +49862186502888 |
| E-mail: | ir@alzchem.com |
| Internet: | www.alzchem.com |
| ISIN: | DE000A2YNT30 |
| WKN: | A2YNT3 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
| EQS News ID: | 857237 |

  

|     |     |
| --- | --- |
|     |     |
| End of News | DGAP News Service |

![show this](https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=857237&application_name=news&site_id=news_data)